Robustness of radiomics features on 0.35 T magnetic resonance imaging for magnetic resonance-guided radiotherapy

被引:0
|
作者
Michalet, Morgan [1 ,2 ]
Valenzuela, Gladis [2 ]
Debuire, Pierre [1 ]
Riou, Olivier [1 ,2 ]
Azria, David [1 ,2 ]
Nougaret, Stephanie [2 ,3 ]
Tardieu, Marion [2 ]
机构
[1] Inst Canc Montpellier, Federat Univ Oncol Radiotherapie Occitanie Mediter, INSERM U1194 IRCM, 208 Ave Apothicaires, F-34298 Montpellier, France
[2] Univ Montpellier, ICM, INSERM, IRCM, 208 Ave Apothicaires, F-34298 Montpellier, France
[3] Inst Canc Montpellier, Serv Imagerie Med, 208 Ave Apothicaires, F-34298 Montpellier, France
关键词
Radiomics; Robustness; MR-guided radiotherapy; SYSTEM;
D O I
10.1016/j.phro.2024.100613
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: MR-guided radiotherapy adds the precision of magnetic resonance imaging (MRI) to the therapeutic benefits of a linear accelerator. Prior to each therapeutic session, an MRI generates a significant volume of imaging data ripe for analysis. Radiomics stands at the forefront of medical imaging and oncology research, dedicated to mining quantitative imaging attributes to forge predictive models. However, the robustness of these models is often challenged. Materials and methods: To assess the robustness of feature extraction, we conducted reproducibility studies using a 0.35 T MR-linac system, employing both a specialized phantom and patient-derived images, focusing on cases of pancreatic cancer. We extracted shape-based, first-order and textural features from patient-derived images and only first-order and textural features from phantom-derived images. The impact of the delay between simulation and first fraction images was also assessed with an equivalence test. Results: From 107 features evaluated, 58 (54 %) were considered as non-reproducible: 18 were uniformly inconsistent across both phantom and patient images, 9 were specific to phantom-based analysis, and 31 to patient-derived data. Conclusion: Our findings show that a significant proportion of radiomic features extracted from this dual dataset were unreliable. It is essential to discard these non-reproducible elements to refine and enhance radiomic model development, particularly for MR-guided radiotherapy in pancreatic cancer.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Dosimetric evaluation of respiratory gating on a 0.35-T magnetic resonance-guided radiotherapy linac
    Charters, John A.
    Abdulkadir, Yasin
    O'Connell, Dylan
    Yang, Yingli
    Lamb, James M.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2022, 23 (09):
  • [2] Multi-parametric optimization of magnetic resonance imaging sequences for magnetic resonance-guided radiotherapy
    Fahad, Hafiz Muhammad
    Dorsch, Stefan
    Zaiss, Moritz
    Karger, Christian P.
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2023, 28
  • [3] Based on 0.35 T magnetic resonance-guided radiotherapy, what are the nonisotropic PTV margins required for conventional prostate radiotherapy?
    Drabble, Joseph
    Das, Prantik
    George, Ben
    Camilleri, Philip
    Morris, Alex
    MEDICAL DOSIMETRY, 2022, 47 (04) : 334 - 341
  • [4] T2-Weighted 4D Magnetic Resonance Imaging for Application in Magnetic Resonance-Guided Radiotherapy Treatment Planning
    Freedman, Joshua N.
    Collins, David J.
    Bainbridge, Hannah
    Rank, Christopher M.
    Nill, Simeon
    Kachelrie, Marc
    Oelfke, Uwe
    Leach, Martin O.
    Wetscherek, Andreas
    INVESTIGATIVE RADIOLOGY, 2017, 52 (10) : 563 - 573
  • [5] Magnetic Resonance-Guided Adaptive Radiotherapy: A Solution to the Future
    Kupelian, Patrick
    Sonke, Jan-Jakob
    SEMINARS IN RADIATION ONCOLOGY, 2014, 24 (03) : 227 - 232
  • [6] The ViewRay System: Magnetic Resonance-Guided and Controlled Radiotherapy
    Mutic, Sasa
    Dempsey, James F.
    SEMINARS IN RADIATION ONCOLOGY, 2014, 24 (03) : 196 - 199
  • [7] Reducing the Toxicity of Radiotherapy for Pancreatic Cancer With Magnetic Resonance-guided Radiotherapy
    Tchelebi, Leila T.
    Zaorsky, Nicholas G.
    Rosenberg, Jennifer C.
    Sharma, Navesh K.
    Tuanquin, Leonard C.
    Mackley, Heath B.
    Ellis, Rodney J.
    TOXICOLOGICAL SCIENCES, 2020, 175 (01) : 19 - 23
  • [8] Online Magnetic Resonance-Guided Radiotherapy (oMRgRT) for Gynecological Cancers
    Portelance, Lorraine
    Corradini, Stefanie
    Erickson, Beth
    Lalondrelle, Susan
    Padgett, Kyle
    van der Leij, Femke
    van Lier, Astrid
    Jurgenliemk-Schulz, Ina
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Radiomics of 0.35T Magnetic Resonance Images for Predicting Pancreatic Cancer Response to Radiotherapy
    Ford, J.
    Simpson, G.
    Spieler, B.
    Portelance, L.
    Mellon, E. A.
    Kwon, D.
    Yang, F.
    Dogan, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S33 - S33
  • [10] Magnetic resonance-guided radiotherapy (MRgRT) for patients with lung cancer
    Crockett, Cathryn
    Chuter, Robert
    Cobben, David
    Dubec, Michael
    Green, Olga
    Hackett, Sara
    McDonald, Fiona
    Robinson, Clifford
    Samson, Pamela
    Shiarli, Anna-Maria
    Straza, Michael
    Verhoeff, Joost
    Vlacich, Gregory
    Werner-Wasik, Maria
    Faivre-Finn, Corinne
    LUNG CANCER, 2021, 156 : S62 - S62